70 and older, any sex, with Cognitive Impairment or Frail Elderly Syndrome. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Delirium by AgePrimary· up to 3 days post-op
The median ages of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method. The Confusion Assessment Method (CAM) is a short diagnostic interview for CAM-defined delirium. Delirium is defined as the sudden change in someone's thinking ability that can have devastating consequences and can be very easily missed due to its frequent subtlety. The 4 CAM features assessed by the CAM include: acute onset or fluctuation, inattention, disorganized thinking, or altered level of consciousness.
Group
Value
95% CI
No Delirium
75
73 – 79
Delirium
77
72 – 80
Number of Participants With or Without Delirium by SexPrimary· up to 3 days post-op
Sex of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
Group
Value
95% CI
No Delirium
94
Delirium
30
No Delirium
70
Delirium
25
Delirium by Body Mass IndexPrimary· up to 3 days post-op
Median body mass index of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
Group
Value
95% CI
No Delirium
28
25 – 32
Delirium
30
26 – 34
Number of Participants With or Without Delirium by College DegreePrimary· up to 3 days post-op
Counts of patients with a college degree who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
Group
Value
95% CI
No Delirium
108
Delirium
36
Participants With an ASA Physical Status Score and the Development of Postoperative DeliriumPrimary· up to 3 days post-op
The ASA Physical Status Classification System assesses and communicates a patient's pre-anesthesia medical co-morbidities and is on a scale of I-VI. This study recruited patients with an ASA physical status of I-III. ASA I is defined as a normal healthy patient, ASA II is defined as a patient with a mild systemic disease, ASA III is defined as a patient with severe systemic disease. ASA physical status of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
Group
Value
95% CI
No Delirium
105
Delirium
44
No Delirium
59
Delirium
11
Number of Participants With or Without Delirium by Metabolic Equivalent of Task Score < 4Primary· up to 3 days post-op
Patients with a metabolic equivalent of task (METS) score \< 4 who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method. The METS score is a ratio of the working metabolic rate relative to the resting metabolic rate and is one way to describe the intensity of an exercise or activity. This was assessed by the preoperative or surgical study staff. A score of \< 3 is for light intesity activities, 3-6 for moderate intensity activities, and ≥ 6 for vigorous intensity activities.
Group
Value
95% CI
No Delirium
45
Delirium
25
Delirium by Total Number of Medications Taken at BaselinePrimary· up to 3 days post-op
Median total number of medications of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
Group
Value
95% CI
No Delirium
8
5 – 10
Delirium
9
7 – 12
Number of Participants With or Without Delirium by Opioid UsePrimary· up to 3 days post-op
Patients with chronic use of opioids who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
Group
Value
95% CI
No Delirium
34
Delirium
21
Number of Participants With or Without Delirium by Alcohol ConsumptionPrimary· up to 3 days post-op
Patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method based on alcohol consumption.
Group
Value
95% CI
No Delirium
98
Delirium
27
Number of Participants With or Without Delirium by Presence of DepressionPrimary· up to 3 days post-op
Patients with depression who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
Group
Value
95% CI
No Delirium
26
Delirium
13
Number of Participants With or Without Delirium by Psychiatric HistoryPrimary· up to 3 days post-op
Patients with a history of psychiatric disorders who did or did not develop post-operative delirium as assessed by the confusion assessment method.
Group
Value
95% CI
No Delirium
14
Delirium
8
Delirium by Mini-cog ScorePrimary· up to 3 days post-op
Median mini-cog score of patients who did or did not develop post-operative delirium as assessed by the confusion assessment method. The Mini-Cog is a brief cognitive screening test for visuospatial representation, recall, and executive function. The test involves that includes recalling three words (banana, sunrise, and chair) and a clock drawing. The Mini-Cog has a scale from 0 to 5, a with higher scores suggesting better cognitive performance. One point is designated for each of 3 words recalled and up to two points for the clock drawing component.
Group
Value
95% CI
No Delirium
4
3 – 5
Delirium
4
2 – 5
Sponsor's own description
The objectives of this study are to determine whether identifying patients with baseline cognitive deficits or frailty predict postoperative delirium.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors.
· NA
· recruiting
NCT07396779 — Cognitive Task-Based Walking Effects on Cognition, Mood, Sleep, and Quality of Life in Older Adults With Brain Fog
· NA
· active not recruiting
NCT07084831 — A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment i
· Phase 3
· recruiting
NCT07125378 — Living Independence Through Functional Training
· Phase 1, PHASE2
· recruiting
NCT07268079 — Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality
· recruiting
Other Brigham and Women's Hospital trials
Trials by the same sponsor.
NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder
· Phase 2
· not yet recruiting
NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE
· suspended
NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ...
· NA
· not yet recruiting
NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation
· NA
· not yet recruiting
NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography
· suspended
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
Last refreshed: 21 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02922634.